Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review
Bioscience Reports · 2023
DOI: 10.1042/bsr20230504 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Bioscience Reports, 2023. Verfasst von Khaled Khudadah und 11 weiteren Autor:innen. Beteiligte Einrichtung: Kuwait Oil Company Ahmadi Hospital, Al Ahmadi, Kuwait. Hauptthemen laut MEDLINE: COVID-19, Respiratory Distress Syndrome, Newborn, Respiratory Distress Syndrome, Pulmonary Surfactants. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: we did not recive funds.
Abstract (Originalsprache)
Patients with COVID-19 exhibit similar symptoms to neonatal respiratory distress syndrome. SARS-CoV-2 spike protein has been shown to target alveolar type 2 lung cells which synthesize and secrete endogenous surfactants leading to acute respiratory distress syndrome in some patients. This was proven by post-mortem histopathological findings revealing desquamated alveolar type 2 cells. Surfactant use in patients with COVID-19 respiratory distress syndrome results in marked improvement in respiratory parameters but not mortality which needs further clinical trials comparing surfactant formulas and modes of administration to decrease the mortality. In addition, surfactants could be a promising vehicle for specific drug delivery as a liposomal carrier, which requires more and more challenging efforts. In this review, we highlight the current reviews and two clinical trials on exogenous surfactant therapy in COVID-19-associated respiratory distress in adults, and how surfactant could be a promising drug to help fight the COVID-19 infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Kuwait Oil Company Ahmadi Hospital, Al Ahmadi, Kuwait.
- Faculty of Medicine, South Valley University, Qena, Egypt.
- Women's Health department, Faculty of Physical Therapy, Cairo University, Cairo, Egypt.
- Faculty of Medicine, Cairo University, Cairo, Egypt.
- Faculty of Medicine, University of Algeirs, Algeirs, Algeria.
- Department of Hematology Laboratory and Blood Transfusion, Hospital Center University Lamine Debaghine, Algeirs, Algeria.
ORCID-Profile: Mohamed Abouzid
Förderung
- we did not recive funds
Zitieren
APA
Khudadah, K., Ramadan, A., Othman, A., Refaey, N., Elrosasy, A., Rezkallah, A., Heseba, T., Moawad, M. H. E. D., Mektebi, A., Elejla, S. A., Abouzid, M., & Abdelazeem, B. (2023). Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review. Bioscience Reports. https://doi.org/10.1042/bsr20230504
Vancouver
Khudadah K, Ramadan A, Othman A, Refaey N, Elrosasy A, Rezkallah A, et al. Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review. Bioscience Reports. 2023. doi:10.1042/bsr20230504
BibTeX
@article{Khudadah2023,
author = {Khudadah, Khaled and Ramadan, Alaa and Othman, Ahmed and Refaey, Neveen and Elrosasy, Amr and Rezkallah, Ayoub and Heseba, Toka and Moawad, Mostafa Hossam El Din and Mektebi, Ammar and Elejla, Sewar A and Abouzid, Mohamed and Abdelazeem, Basel},
title = {Surfactant replacement therapy as promising treatment for COVID-19: an updated narrative review},
journal = {Bioscience Reports},
year = {2023},
doi = {10.1042/bsr20230504}
}
EUVIMED